Rituximab for refractory polymyositis: an open-label prospective study.
2007 · PubMed · 112 citations
L
Ling Yin Ho
Tai Po Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
2.1K
Citations
24
h-index
33
i10-index
Ling Yin Ho is an academic researcher from Tai Po Hospital. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & Rheumatoid Arthritis Research and Therapies & Systemic Sclerosis and Related Diseases. The author has an h-index of 24, co-authored 72 publications.
ORCID: 0000-0003-3427-327XPapers by this author
worksLong-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis
2020 · Annals of the Rheumatic Diseases · 72 citations
https://doi.org/10.1136/annrheumdis-2020-217178
Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
2018 · Arthritis Research & Therapy · 61 citations
https://doi.org/10.1186/s13075-017-1498-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat